Recruiting Breast Cancer Studies in Hinsdale
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
The purpose of this open-label, multicenter, phase IIIb, single-arm study is to characterize the efficacy and safety of the combination of ribociclib and standard adjuvant endocrine therapy (ET) on in...
Evexomostat Plus PI3K or AKT Inhibitor and Fulvestrant in Patients With a PI3K Alteration and HR+/Her2- Breast Cancer
This is a Phase 1b/2, open-label, parallel-arms pilot study in men and post-menopausal women with hormone receptor positive (HR+), HER2- advanced or metastatic breast cancer with an alteration in the ...
About Breast Cancer Clinical Trials in Hinsdale
Breast cancer is a disease in which cells in the breast grow out of control. It is the most common cancer in women worldwide and can also occur in men. Treatment options include surgery, radiation, chemotherapy, hormone therapy, and targeted therapies.
There are currently 2 breast cancer clinical trials recruiting participants in Hinsdale, ILLINOIS. These studies are seeking a combined 1,452 participants. Research is being sponsored by Novartis Pharmaceuticals, SynDevRx, Inc.. Clinical trial participation is free and participants receive study-related medical care at no cost.
Breast Cancer Clinical Trials in Hinsdale — FAQ
Are there breast cancer clinical trials in Hinsdale?
Yes, there are 2 breast cancer clinical trials currently recruiting in Hinsdale, ILLINOIS. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Hinsdale?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Hinsdale research site will contact you about next steps.
Are clinical trials in Hinsdale free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Hinsdale studies also compensate for your time and travel.
What breast cancer treatments are being tested?
The 2 active trials in Hinsdale are testing new therapies including novel drugs, biologics, and treatment approaches for breast cancer.
Data updated March 2, 2026 from ClinicalTrials.gov